A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

March 31, 2026

Conditions

Prostate CancerProstate Cancer (Adenocarcinoma)Fluorescence Imaging

Interventions

DRUG

AS1986NS

Single dose, IV, 100 µg of AS1986NS

Trial Locations (2)

Linkou Chang Gung Memorial Hospital, Taoyuan

Icahn School of Medicine at Mount Sinai (ISMMS), New York

All Listed Sponsors

lead

Antelope Surgical Solutions, Inc

INDUSTRY